Clinical Value of Motion Synchronization for Prostate SBRT
Sean Collins, M.D., Ph.D. | MedStar Georgetown University Hospital, Georgetown University School of Medicine, Washington, D.C. | ASTRO 2022 AEx Academy
Long-Term Outcomes from a Multi-Center Trial of Stereotactic Body Radiotherapy for Low- and Intermediate-Risk Prostate Cancer
Stereotactic Body Radiation Therapy in Treating Patients with Oligo-metastatic Hormone-Naïve Prostate Cancer
Primary prostate cancer, unfavorable, high risk prostate cancer, relapsed and oligometastatic prostate cancer
Rationale and Overview of CyberKnife® Prostate SBRT
Strategies in prostate cancer treatment (de)escalation
SBRT of Prostate Cancer Oligometastases: Radical Treatment or Expensive Palliation?
Prostate Cancer with Synchronous Bone Oligometastases: Is the Radical Treatment Approach Justified?
Disease Site Focused Clinical Roadmap: Prostate
Dosimetric Comparison of Cyberknife with MLC versus Linac-based Intensity Modulated Radiation Therapy in Prostate Cancer